• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CWWeekly Feb. 4th 2008 Issue

CWWeekly Feb. 4th 2008 Issue

February 8, 2008
CenterWatch Staff

Top News

Synarc Adds Hong Kong to List of Global Research Centers

San Francisco, Calif.-based contract research organization (CRO) Synarc launched a dedicated clinical research center in Hong Kong’s central district. The unit is more than 3,000 square-feet and operated by a dozen local staff members. A typical Synarc clinic is about 20,000 to 30,000 square-feet. Synarc conducts all its clinical trials at either its own sites or at sites run by partners. The company now owns 11 sites in Denmark, Estonia, Lithuania, Brazil, Romania, Poland, Czech Republic and mainland China.

PPD Breaks into China Central Lab Business

Wilmington, N.C.-based contract research organization (CRO) PPD made its first foray into the rapidly growing Chinese central laboratory market with the launch of its own unit, in cooperation with Peking Union Lawke Biomedical Development Limited (PUL). The exclusive agreement allows PPD to establish a commercial entity located on a separate campus near Peking Union Medical College Hospital (PUMCH). The facility is headed by Mayo Clinic–educated Jian Ho, M.D, Ph.D. The PUL has 60 highly trained local personnel.

Other breaking news...

Clinical Data signs agreement with Affymetrix...
Phase Forward reports strong growth...

Company Profile: An interview with Ibrahim Farr, MD, PhD, chief executive officer, Pivotal

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing